5 Key Takeaways

• 1

  A study found that 79% of gestational diabetes patients maintained glycemic control using metformin and glyburide.

• 2

  The oral glucose-lowering strategy did not demonstrate noninferiority to insulin in preventing large-for-gestational-age infants.

• 3

  Maternal hypoglycemia occurred more frequently in the oral agent group (20.9%) compared to the insulin group (10.9%).

• 4

  Adverse effects such as nausea, diarrhea, and vomiting were reported significantly more often in the oral agent group.

• 5

  Patients using oral agents reported higher satisfaction with their treatment compared to those receiving insulin.